John Crowley

Chief Financial Officer at Fusion Pharmaceuticals

Speaker

Mr. Crowley brings over 20 years of global finance and operational experience in the life sciences as the Chief Financial Officer of Fusion Pharmaceuticals, Inc., an organization he led through an initial public offering and evolution from a research organization with multiple Phase 1 and 2 assets in the clinic. He most recently served as Executive Vice President and Chief Financial Officer of Merus, Inc., a publicly traded oncology company, where he led the execution of financial strategy and operations as well as investor relations activities. Prior to Merus, Mr. Crowley served as the Corporate Senior Vice President, Corporate Controller and Chief Accounting Officer of Charles River Laboratories, Inc. where he implemented a finance transformation initiative to restructure the finance operating model in support of an aggressive acquisition strategy. Previously, Mr. Crowley held senior corporate finance positions at Ironwood Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Sunovion Pharmaceuticals, Inc., where he supported several commercial launches, financings, and business development transactions in rapidly growing companies. Mr. Crowley is a Certified Public Accountant and graduated Summa Cum Laude from Babson College with BS degrees in both Economics and Accountancy.